金沙平台

金沙平台

金沙平台

金沙平台


This data might not be the latest available

Upcoming events金沙官网手机下载app

J.P. Morgan European Healthcare Conference [Management] 金沙平台

H1 2020 Results金沙平台


金沙官网手机下载app

 


金沙官网手机下载app

金沙平台

金沙官网手机版

Thomas Kudsk Larsen

金沙官网手机网址

Henry Wheeler

Oncology

金沙官网登录注册

Josie Afolabi

BioPharmaceuticals (Respiratory & Immunology)

金沙官网手机下载app

Craig Marks

Finance, fixed income

金沙官网登录注册

Christer Gruvris

BioPharmaceuticals (CV, Metabolism)

金沙官网网址

Tom Waldron

Other medicines

金沙官网9304

Jennifer Kretzmann

Corporate access, retail investors

金沙登录网址

Nick Stone

BioPharmaceuticals (Renal), ESG

US general enquiries


  • 金沙平台

    Please find relevant shareholder 资讯rmation and shareholder tools on this 页面


  • 金沙平台

    Answers to frequently asked shareholder questions


  • 金沙平台

    We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance